These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. Bhavnani BR; Stanczyk FZ J Clin Endocrinol Metab; 2012 Mar; 97(3):756-9. PubMed ID: 22205711 [No Abstract] [Full Text] [Related]
63. Response to the Letter: "Transdermal vs oral estrogen therapy and venous thromboembolism: upgrade the level of evidence" by Scarabin MC, et al. Mohammed K; Murad MH J Clin Endocrinol Metab; 2016 Feb; 101(2):L32. PubMed ID: 26840116 [No Abstract] [Full Text] [Related]
64. Estrogen therapy and liver function--metabolic effects of oral and parenteral administration. von Schoultz B; Carlström K; Collste L; Eriksson A; Henriksson P; Pousette A; Stege R Prostate; 1989; 14(4):389-95. PubMed ID: 2664738 [TBL] [Abstract][Full Text] [Related]
66. Three-year follow-up on the effects of transdermal estrogen. Parfitt AM Ann Intern Med; 1997 May; 126(9):742. PubMed ID: 9139568 [No Abstract] [Full Text] [Related]
67. Steroidal oestrogens added to list of known human carcinogens. Nelson R Lancet; 2002 Dec 21-28; 360(9350):2053. PubMed ID: 12504409 [No Abstract] [Full Text] [Related]
68. [Extradigestive administration of estrogens: value in the treatment of menopause]. Basdevant A Rev Med Interne; 1988; 9(4):355-8. PubMed ID: 3222573 [No Abstract] [Full Text] [Related]
70. Possible tachyphylaxis with transdermal therapy?Nikki Kersey ST1 CSRH, Paula Briggs Consultant CSRH. Briggs P Post Reprod Health; 2019 Jun; 25(2):111-112. PubMed ID: 31192756 [No Abstract] [Full Text] [Related]
71. Patch up the menopause. Stampfer MJ; Sacks FM Lancet; 1988 Jun; 1(8598):1332. PubMed ID: 2897573 [No Abstract] [Full Text] [Related]
72. Addendum: Ospemifene (Osphena) for dyspareunia (Med Lett Drugs Ther 2013; 55:55). Med Lett Drugs Ther; 2013 Oct; 55(1427):84. PubMed ID: 24278971 [No Abstract] [Full Text] [Related]
73. [Oral therapy with estrogens]. SCHILLER H Wien Med Wochenschr; 1951 Dec; 101(49):949-51. PubMed ID: 14922862 [No Abstract] [Full Text] [Related]
74. Addendum for Ann Fam Med; 2022; 20(1):4. PubMed ID: 35074760 [No Abstract] [Full Text] [Related]
75. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41). Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825 [No Abstract] [Full Text] [Related]
76. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review. Fournier A Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283 [TBL] [Abstract][Full Text] [Related]
77. Hormone therapy and brain structure in postmenopausal women. Molano JR Neurology; 2016 Aug; 87(9):e100-2. PubMed ID: 27572433 [No Abstract] [Full Text] [Related]
78. Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women? Clarkson TB; Karas RH Menopause; 2007; 14(6):963-7. PubMed ID: 17909452 [No Abstract] [Full Text] [Related]
79. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery. Baker VL Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545 [TBL] [Abstract][Full Text] [Related]
80. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]. Canonico M; Scarabin PY Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]